Enhancing Cell Nucleus Accumulation and DNA Cleavage Activity of Anti-Cancer Drug via Graphene Quantum Dots

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Wang, Chong ^a   Wu, Congyu ^b   Zhou, Xuejiao ^b   Han, Ting ^b   Xin, Xiaozhen ^a   Wu, Jiaying ^a   Zhang, Jingyan ^a   Guo, Shouwu ^b  

^a EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Shanghai Jiao Tong University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; GRAPHITE; QUANTUM DOT;

ARTICLE; BIOLOGICAL MODEL; CELL NUCLEUS; CHEMISTRY; DNA CLEAVAGE; DRUG EFFECT; HUMAN; INTRACELLULAR SPACE; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; CELL NUCLEUS; DNA CLEAVAGE; DOXORUBICIN; GRAPHITE; HUMANS; INTRACELLULAR SPACE; MODELS, BIOLOGICAL; QUANTUM DOTS;

EID: 84885097031     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep02852     Document Type: Article

References (51)

1. Devadasu, V. R., Bhardwaj, V. & Kumar, M. N. V. R. Can Controversial Nanotechnology Promise Drug Delivery? Chem. Rev. 113, 1686-1735 (2012).
2. Peer, D. et al. Nanocarriers as an emerging platform for cancer therapy. Nature Nanotech. 2, 751-760 (2007).
3. Prato, M., Kostarelos, K. & Bianco, A. Functionalized Carbon Nanotubes in Drug Design and Discovery. Acc. Chem. Res. 41, 60-68 (2007).
4. Mane, S. R. et al. AmPhiPhilic Homopolymer Vesicles as Unique Nano-Carriers for Cancer Therapy. Macromolecules 45, 8037-8042 (2012).
5. Zhou, H. et al. Synthesis and Characterization of AmPhiPhilic Glycidol2Chitosan2Deoxycholic Acid Nanoparticles as a Drug Carrier for Doxorubicin. Biomacromolecules 11, 3480-3486 (2010).
6. Tkachenko, A. G. et al. Multifunctional Gold Nanoparticle2Peptide Complexes for Nuclear Targeting. J. Am. Chem. Soc. 125, 4700-4701 (2003).
7. Song, J., Zhou, J.&Duan,H. Self-Assembled Plasmonic Vesicles of SERS-Encoded AmPhiPhilic Gold Nanoparticles for Cancer Cell Targeting and Traceable Intracellular Drug Delivery. J. Am. Chem. Soc. 134, 13458-13469 (2012).
8. Kim, J. et al. Designed Fabrication of a Multifunctional Polymer Nanomedical Platform for Simultaneous Cancer-Targeted Imaging and Magnetically Guided Drug Delivery. Adv. Mater. 20, 478-483 (2008).
9. Muhammad, F. et al. Ph-Triggered Controlled Drug Release from Mesoporous Silica Nanoparticles via Intracelluar Dissolution of ZnO Nanolids. J. Am. Chem. Soc. 133, 8778-8781 (2011).
10. Zhao, YX. et al.DNA OrigamiDelivery System for Cancer Therapy with Tunable Release Properties. ACS Nano 6, 8684-8691 (2012).
11. Paliwal, S. R. et al. Estrogen-Anchored Ph-Sensitive Liposomes as Nanomodule Designed for Site-Specific Delivery of Doxorubicin in Breast Cancer Therapy. Mol. Pharm. 9, 176-186 (2011).
12. Pan, L. et al. Nuclear-Targeted Drug Delivery of TAT Peptide-Conjugated Monodisperse Mesoporous Silica Nanoparticles. J. Am. Chem. Soc. 134, 5722-5725 (2012).
13. K. C., R. B., Thapa, B. & Xu, P. Ph and Redox Dual Responsive Nanoparticle for Nuclear Targeted Drug Delivery. Mol. Pharm. 9, 2719-2729 (2012).
14. Dobrovolskaia, M. A. & McNeil, S. E. Immunological properties of engineered nanomaterials. Nature Nanotech. 2, 469-478 (2007).
15. Mao, H. Y. et al. GraPhene: Promises, Facts, Opportunities, and Challenges in Nanomedicine. Chem. Rev. 113, 3407-3424 (2013).
16. Feng, L. & Liu, Z. GraPhene in biomedicine: Opportunities and challenges. Nanomedicine 6, 317-324 (2011).
17. Zhang, Y., Nayak, T. R., Hong, H. & Cai, W. GraPhene: A versatile nanoplatform for biomedical applications. Nanoscale 4, 3833-3842 (2012).
18. Sun, X. et al. Nano-GraPhene oxide for cellular imaging and drug delivery. Nano Res. 1, 203-212 (2008).
19. Zhou, L. et al. GraPhene Oxide Noncovalent Photosensitizer and Its Anticancer Activity In Vitro. Chem. Eur. J. 17, 12084-12091 (2011).
20. Huang, P. et al. Folic Acid-Conjugated GraPhene Oxide loaded with Photosensitizers for Targeting Photodynamic Therapy. Theranostics 1, 240-250 (2011).
21. Yang, X. et al.Multi-Functionalized graPhene oxide based anticancer drug-Carrier with dual-Targeting function and Ph-Sensitivity. J. Mater. Chem. 21, 3448-3454 (2011).
22. Yang, K. et al. GraPhene in Mice: Ultrahigh In Vivo Tumor Uptake and Efficient Photothermal Therapy. Nano Lett. 10, 3318-3323 (2010).
23. Liu, Z., Robinson, J. T., Sun, X. & Dai, H. PEGylated NanograPhene Oxide for Delivery of Water-Insoluble Cancer Drugs. J. Am. Chem. Soc. 130, 10876-10877 (2008).
24. Zhang, L., Xia, J., Zhao, Q., Liu, L. & Zhang, Z. Functional GraPhene Oxide as a Nanocarrier for Controlled Loading and Targeted Delivery of Mixed Anticancer Drugs. Small 6, 537-544 (2010).
25. Ren, H. et al. DNA Cleavage System of Nanosized GraPhene Oxide Sheets and Copper Ions. ACS Nano 4, 7169-7174 (2010).
26. Zheng, B. et al. Nuclease Activity and Cytotoxicity Enhancement of the DNA Intercalators via GraPhene Oxide. J. Phys. Chem. C 116, 15839-15846 (2012).
27. Zhou, X. et al. Photo-Fenton Reaction of GraPhene Oxide: A New Strategy to Prepare GraPhene Quantum Dots for DNA Cleavage. ACS Nano 6, 6592-6599 (2012).
28. David, S., Sigman, R. L., David, M. & Perrin, L. P. Nucleic Acid Chemistry of the Cuprous Complexes of 1,10-Phenanthroline and Derivatives (Institute of Inorganic Chemistry, University of Basel, Place, 1996).
29. Carter, S. K. Adriamycin-A Review. J. Natl. Cancer Inst. 55, 1263-1263 (1975).
30. Swift, L. P., RePhaeli, A.,Nudelman, A., Phillips, D. R.&Cutts, S. M. Doxorubicin-DNA Adducts Induce a Non-Topoisomerase II-Mediated Form of Cell Death. Cancer Res. 66, 4863-4871 (2006).
31. Feinstein, E., Canaani, E. & Weiner, L. M. Dependence of Nucleic Acid Degradation on in situ Free-Radical Production by Adriamycin. Biochemistry 32, 13156-13161 (1993).
32. William Lown, J., Sim, S. K., Majumdar, K. C. & Chang, R. Y. Strand scission of DNA by bound adriamycin and daunorubicin in the presence of reducing agents. Biochem. BioPhys. Res. Commun. 76, 705-710 (1977).
33. Kalsbeck, W. A. & Thorp, H. H. Determining Binding Constants of Metal Complexes to DNA by Quenching of the Emission of Pt2(pop)44-(pop 5 P2O5H22-). J. Am. Chem. Soc. 115, 7146-7151 (1993).
34. Liu, Z., Sun, X., Nakayama-Ratchford, N. &Dai, H. Supramolecular Chemistry on Water-Soluble Carbon Nanotubes for Drug Loading and Delivery. ACS Nano 1, 50-56 (2007).
35. Yang, X. et al. High-Efficiency Loading and Controlled Release of Doxorubicin Hydrochloride on GraPhene Oxide. J. Phys. Chem. C 112, 17554-17558 (2008).
36. Capranico, G., Soranzo, C. & Zunino, F. Single-Strand DNA Breaks Induced by ChromoPhore-Modified Anthracyclines in P388 Leukemia Cells. Cancer Res. 46, 5499-5503 (1986).
37. Ravid, A. et al. 1,25-Dihydroxyvitamin D3 Enhances the Susceptibility of Breast Cancer Cells to Doxorubicin-Induced Oxidative Damage. Cancer Res. 59, 862-867 (1999).
38. Xi, J., Zhou, L. & Dai, H. Drug-Loaded chondroitin sulfate-Based nanogels: Preparation and characterization. Colloids Surf. B Biointerfaces 100, 107-115 (2012).
39. Wu, C. et al. Cellular Internalization and Low Cytotoxicity of GraPhene Quantum Dots. Adv. Healthcare Mater. 10.1002/adhm.201300066 (2013).
40. Shuhendler, A. et al. A novel doxorubicin-Mitomycin C co-Encapsulated nanoparticle formulation exhibits anti-Cancer synergy in multidrug resistant human breast cancer cells. Breast Cancer Res. Treat. 119, 255-269 (2010).
41. Zaki, N. M. & Tirelli, N. Gateways for the intracellular access of nanocarriers: A review of receptor-Mediated endocytosis mechanisms and of strategies in receptor targeting. Expert Opin. Drug Deliv. 7, 895-913 (2010).
42. Mu, Q. et al. Size-Dependent Cell Uptake of Protein-Coated GraPhene Oxide Nanosheets. ACS Appl. Mater. Interfaces 4, 2259-2266 (2012).
43. Du, J. Z., Du, X. J., Mao, C. Q. & Wang, J. Tailor-Made Dual Ph-Sensitive Polymer-Doxorubicin Nanoparticles for Efficient Anticancer Drug Delivery. J. Am. Chem. Soc. 133, 17560-17563 (2011).
44. Su, J., Chen, F., Cryns, V. L. & Messersmith, P. B. Catechol Polymers for PhResponsive, Targeted Drug Delivery to Cancer Cells. J. Am. Chem. Soc. 133, 11850-11853 (2011).
45. Paine, P. L.,Moore, L. C. &Horowitz, S. B. Nuclear envelope permeability. Nature 254, 109-114 (1975).
46. Chan, C. K. & Jans, D. A. Supramolecular structure and nuclear targeting efficiency determine the enhancement of transfection by modifed polylysines. Gene Ther. 7, 1690-1697 (2000).
47. Lam, W., Leung, C. H., Chan, H. L. & Fong, W. F. Toxicity and DNA binding of dextran-Doxorubicin conjugates in multidrug-Resistant KB-V1 cells: Optimization of dextran size. Anti-Cancer Drug 11, 377-384 (2000).
48. Gottesman, M. M., Fojo, T. & Bates, S. E. Multidrug resistance in cancer: Role of ATP-Dependent transporters. Nat. Rev. Cancer 2, 48-58 (2002).
49. Gottesman, M. M. Mechanism Of Cancer Drug Resistance. Annu. Rev. Med. 53, 615-627 (2002).
50. Jiang, Q. et al. DNA Origami as a Carrier for Circumvention of Drug Resistance. J. Am. Chem. Soc. 134, 13396-13403 (2012).
51. Chen, Y., Bathula, S. R., Li, J. & Huang, L. Multifunctional Nanoparticles Delivering Small Interfering RNAand Doxorubicin OvercomeDrug Resistance in Cancer. J. Biol. Chem. 285, 22639-22650 (2010).